← Eichor
Study identifier: NCT05842603 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients

Condition: Myeloproliferative Disorders · Leukemia  ·  Sponsor: Massachusetts General Hospital

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this study is to see if patients with myeloproliferative disorders are able to successfully complete the Cardiac Lifestyle Program(CLP). The goal of the CLP is to teach patients how to become more active and eat healthier foods. The name of the intervention used in this research study is: Cardiac Lifestyle Program (a 12-week, tailored nutrition and physical activity program)

This description comes directly from the study's public registry record.

Talk to the study team

Gabriela Hobbs, MD  ·  617-724-1124  ·  ghobbs@partners.org

Gabriella Hobbs, MD  ·  617-724-1124  ·  ghobbs@partners.org

Always discuss trial participation with your own doctor first.

Locations (3)

Brigham and Women's HospitalBoston, Massachusetts, United StatesRecruiting
Dana-Farber Cancer InstituteBoston, Massachusetts, United StatesNot Yet Recruiting
Massachusetts General Hospital Cancer CenterBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05842603